AKT1 and cancer: Additionally, two promising anti-cancer agents targeting AKT1 (the cytotoxic alkylphospholipids Perifosine and Miltefosine) bind to the PH domain, which blocks membrane localization of AKT1 and results in a reduction in the level of AKT1 phosphorylation [9].